24863
C18 3'-sulfo Galactosylceramide (d18:1/18:0)
Cayman Chemical
DESCRIPTION
A sulfatide; a minor endogenous sphingolipid; levels are increased in brain tissue isolated from ASA-KO mice; plasma levels positively correlate with disability progression in patients with relapsing-remitting multiple sclerosis using the Expanded Disability Status Scale; increased in plasma from patients with MLD; brain levels decrease with age in mice and humans
DETAILS
- Inchi: InChI=1S/C42H81NO11S/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-32-38(46)43-35(36(45)31-29-27-25-23-21-19-16-14-12-10-8-6-4-2)34-52-42-40(48)41(54-55(49,50)51)39(47)37(33-44)53-42/h29,31,35-37,39-42,44-45,47-48H,3-28,30,32-34H2,1-2H3,(H,43,46)(H,49,50,51)/b31-29+/t35-,36+,37+,39-,40+,41-,42+/m0/s1
- Purity: ≥98%
- Raptas: Product Type|Biochemicals|Lipids|Sphingolipids||Research Area|Endocrinology & Metabolism|Inborn Errors of Metabolism||Research Area|Immunology & Inflammation|Autoimmunity||Research Area|Lipid Biochemistry|Sphingolipids||Research Area|Neuroscience|Neurodegenerative Disorders|Multiple Sclerosis
- Smiles: O[C@@H]1[C@@H](OS(O)(=O)=O)[C@@H](O)[C@@H](CO)O[C@H]1OC[C@H](NC(CCCCCCCCCCCCCCCCC)=O)[C@H](O)/C=C/CCCCCCCCCCCCC
- Inchikey: GQQZXRPXBDJABR-BDZNYNMQSA-N
- Cas Number: 244215-65-4
- Formulation: A solid
- Storage Temp: -20
- Shipping Temp: -20
- Formula Markup: C42H81NO11S
- Formula Weight: 808.2
- Shelf Life Days: 1460
Equivalent Items
| ... Loading